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To describe the long-term eects of nasal continuous positive airway pressure (CPAP) on the rate of trac car
accidents, excessive daytime sleepiness (EDS) and mood in patients with obstructive sleep apnoea syndrome
(OSAS), we investigated the changes of these parameters before and after nasal CPAP treatment using a
questionnaire. Seventy-five male patients who were diagnosed with severe OSAS by polysomnography were
evaluated for driving competence, by looking at their driving history for 2 yr, for EDS by the Epwarth Sleepiness
Scale (ESS) and for mood by the Self-related Depression Scale (SDS), and then underwent nasal CPAP treatment.
After 2 yr of treatment, questionnaires inquiring about the patients’ use of CPAP, their ESS, SDS and driving
history during treatment were sent to the patients. A total of 47 patients (63%) responded to these questionnaires.
Forty-six of the 47 responders had continued to use the nasal CPAP and completed the questionnaire. No trac
car accidents were observed among the 39 routine car users during treatment, while 13 of 39 patients (33%) had had
car accidents before treatment. Although near-miss accidents had been reported by 32 of 39 patients (82%) before
treatment, only four patients reported near-miss accidents during nasal CPAP treatment. The mean score of ESS
was significantly (P5001) reduced in 46 patients after nasal CPAP. The mean score of SDS was also decreased
(P5001) after nasal CPAP in 46 patients. Although 26 of 41 patients had been depressive on SDS before
treatment, the mood was improved in 13 patients after nasal CPAP.
These results suggest that long-term nasal CPAP treatment reduces the rate of trac car accidents and improves
the EDS and the mood in patients with OSAS.
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Excessive daytime sleepiness (EDS) is a primary symptom
of patients with obstructive sleep apnoea syndrome
(OSAS), leading to trac, work and domestic accidents
(1–4). The high prevalence of trac accidents, especially,
may directly threaten patients’ lives. Recently, Teran-
Santos et al. have clearly shown that there is a strong
association between sleep apnoea, as measured by the
apnoea-hypopnoea index and the risk of trac accidents
(5). It is also reported that neuropsychological deficits and
lowered mood, as well as EDS, are found in patients with
OSAS (6–8). These neuropsychological deficits have a
profound impact on the patients’ ability to function on a
daily basis.
Nasal continuous positive airway pressure (CPAP) has
been a first-line treatment for patients with OSAS in recentReceived 24 March 1999 and accepted in revised form 31 August
1999.
Correspondence should be addressed to: Hitoshi Yamamoto, MD
First Department of Internal Medicine, Nihon University School
of Medicine, 30-1 Oyaguchi Kamimachi, Itabashi-Ku, Tokyo,
Japan 173-8610. Fax: 81 33972 2893.
0954-6111/00/010087+04 $35?00/0years (9–11). Treatment with nasal CPAP has been shown
to improve nocturnal apnoea and oxygen desaturation (9–
10), objective daytime sleepiness (12–15), cognitive function
(12–14), mood (16–17) and well-being (12–13). However,
these improvements were only found for a relatively short
period after treatment. We first described that nasal CPAP
reduced the rate of trac accidents with improvement of
EDS for 1 yr during treatment (18), although the number of
subjects was small. Therefore, the aims of this study were to
confirm and to assess the long-term eects of nasal CPAP
on EDS, mood and driving competence in a large number
of subjects.
Subjects and method
Of all the men referred to the outpatients clinic in our
hospital for suggested OSAS between 1992–96, 75 subjects
were included in this study. Their mean age and body mass
index (BMI) were 495+108 (SD) years and 292+54 kg
m72, respectively. All subjects gave informed consent to
this study and this study was approved by the Institutional
Human Investigation Committee of Nihon University.
They underwent full-night polysomnography (PSG) with# 2000 HARCOURT PUBLISHERS LTD
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airflows at nose and mouth (thermistor), movements of rib
cage and abdomen (inductance plethysmography) and
oxygen saturation (SaO2). The analysis and interpretation
of PSG data were performed by standard techniques (19).
They were evaluated for EDS and the mood using the
Epwarth Sleepiness Scale (ESS) (20) and the Self-rating
Depression Scale (SDS) (21). ESS and SDS were evaluated
by the patients themselves. Sixty-four of the 75 subjects had
a driver’s license and recounted their detailed driving
history for the previous 2 yr in response to the following
questions: 1. How often do you drive? (seldomly, some-
times, frequently, always); 2. Have you had car accidents?;
3. If so, how many accidents and what kind of accidents did
you have?; 4. Did you have any near-miss car accidents?; 5.
If so, how many times?
Nasal CPAP titration using a commercial CPAP device
(7300H, France Bed Medical, Tokyo, Japan) was per-
formed to abolish apnoea and snoring completely and to
maintain SaO2490% during sleep and the optimal CPAP
level was determined. The subjects were encouraged to use
nasal CPAP at the optimal levels every night at home. They
were asked to come to the outpatient clinic every 2 or 3
months. After 2 yr treatment, a questionnaire inquiring
about the use of nasal CPAP, the ESS, SDS and driving
history during treatment was sent to each patient.
STATISTICAL ANALYSIS
The changes in ESS and SDS, with and without nasal
CPAP, were compared with the paired t-test. The compar-
isons of baseline characteristics between the subjects, with
and without trac accidents and near-miss accidents, were
performed using the non-paired t-test. Dierences were
considered significant where P5005.
Results
Forty-seven of 75 subjects (625%) returned the question-
naires. Only one patient stated that he no longer used nasal
CPAP because of discomfort from the nasal mask. The
mean duration and CPAP level were 388+82 months andTABLE 1. Comparison of baseline characteristics between the pa
TA()
No of Patients 13
Age (year) 441+99
BMI (kg m72) 324+68
AHI (No h71) 600+175
Mean SaO2 (%) 857+85
Lowest SaO2 (%) 633+92
ESS 144+43
SDS 466+68
TA: trac accident; BMI: body mass index; AHI: apnoea-hypo
depression scale.106+24 cm H2O, respectively. Patient compliance of
nasal CPAP was 978%. There were no significant
dierences in baseline characteristics, PSG parameters,
ESS and SDS scores and the rate of trac accidents
between the responders and the non-responders. However,
there was a tendency of high ESS scores in the responders
compared with the non-responders (126+49 vs. 103+45,
P501).
DRIVING HISTORY
Thirty-nine of the 46 responders (84%) had drivers licenses
and a history of routine driving. Thirteen of these 39 drivers
(33%) had had trac car accidents (all collisions) and 32
(82%) had had near-miss car accidents during the 2 yr
before treatment. The 13 patients who had had trac
accidents were more obese and had shown higher scores of
SDS than those who had not had accidents before
treatment (Table 1). Thirty-two patients who had had
near-miss accidents had more severe oxygen desaturation
during sleep and higher scores of ESS than those who had
not had near-miss accidents before treatment (Table 2). No
car accidents were observed, and near-miss car accidents
decreased to only four patients (10%), after treatment
(Fig. 1).
ESS AND SDS
The mean scores of ESS were significantly decreased from
126+49 to 36+27 during nasal CPAP in 46 patients
(P500001). Forty-one patients completed SDS measure-
ments before and after nasal CPAP. The mean score of SDS
was 429+78 before treatment. Twenty-six of 41 patients
(634%) had more than 41 points on their SDS score, which
was considered a depressive state (21). The mean score of
SDS was significantly reduced to 351+83 points after
nasal CPAP (P500001). Thirteen of 26 patients (50%)
with a depressive state before treatment were in the normal
range (less than 40 points) on SDS score after nasal CPAP.
There were no significant dierences in age, BMI and PSG
parameters between the normal group and the depressive










pnoea index; ESS: Epwarth sleepiness scale; SDS: self-rated
FIG. 1. Trac accidents and near-miss accident with and
without nasal CPAP. TA: trac accident; NM: near-miss
accident.
TABLE 2. Comparison of baseline characteristics between the patients who had had and hadn’t had near-miss accidents
NM() NM(7) P-value
No of Patients 32 7
Age (year) 470+105 541+105 n.s.
BMI (kg m72) 302+59 261+25 n.s. (501)
AHI (No h71) 550+175 584+254 n.s.
Mean SaO2 (%) 851+86 921+43 5005
Lowest SaO2 (%) 631+102 710+58 n.s.
ESS 138+45 81+45 n.s.
SDS 434+71 403+104 5005
NM: near-miss accident; BMI: body mass index; AHI: apnoea-hypopnoea index; ESS: Epwarth sleepiness scale; SDS: self-
rated depression scale.
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Out results showed that long-term nasal CPAP improved
the EDS and reduced the rate of trac car accidents and
near-miss accidents. Although we first described that nasal
CPAP decreased trac car accidents during 1 yr of
treatment, the number of subjects was small (18). Recently,
several studies of the eects of CPAP on trac car
accidents have been reported with large numbers of subjects
(22–24). All these investigations demonstrated that nasal
CPAP reduced trac car accidents rate after 1 yr of
treatment. The present results are consistent with these
reports and confirmed our previous results. Although the
decrease in number of car accidents and near-misses may be
due to improvement of EDS, we could not evaluate directly
between the decrease in car accidents and the improvement
of EDS during treatment, and did not observe significant
dierences in ESS between the patients who had and didn’t
have car accidents before treatment. However, the mean
score of ESS in the subjects was relatively high, even in the
26 patients who hadn’t had car accidents. Although they
had had no car accidents before, they were hypersomnolent
and might have presented a dangerous risk of car accidents.
Actually, all 26 patients had experienced near-miss acci-
dents. Since we found that the patients who had had near-miss accidents were more sleepy and desaturated during
sleep than those without near-misses, the severity of OSAS
and EDS might have been related to driving competence.
Cassel et al. (22) showed that improvements in the Multiple
Sleep Latency Test (MSLT), an objective measurement of
EDS, were simultaneously found in patients with OSAS
with the reduction of car accidents after 1 yr of treatment
with nasal CPAP. Therefore, it is likely that EDS played a
substantial role in the occurrence of trac car accidents.
We observed the eects of nasal CPAP on trac accidents
for 2 yr after treatment, while recent reports have observed
them for 2, 6 and 12 months (22–24). Since we found no car
accidents and only four near-miss accidents during treat-
ment, it is conceivable that the positive eects of nasal
CPAP on driving competance continue for a longer time
than previously described.
Before treatment, the mean score of SDS was relatively
high (429+78). Since the normal range of SDS is less than
40 points (21), a depressive state was found in 634% of the
subjects. In patients with OSAS, neuropsychological
symptoms may be part of the initial presentation. The
patients with OSAS often exhibit increased anxiety, poor
concentration and symptoms of depression (25). Previous
reports have demonstrated that depression and fatigue are
improved after short-term nasal CPAP treatment (15–17).
Engleman et al. (17) found that objective sleepiness and
mood were improved after 3 months of treatment with
nasal CPAP. We also showed that the score on SDS was
significantly reduced and the depressive state was normal-
ized in 13 of 26 patients after 2 yr treatment with nasal
CPAP. This eect may contribute to an improvement of
patients’ quality of life because most patients with severe
OSAS compromise their activities in social life. We found
the significant dierences in SDS score between the patients
with and without trac accidents before treatment.
Although the patients who had had car accidents were
more depressive compared with those who had not had
accidents, it is unclear how depression contributes to
driving competence. Both the sleep disruption produced
by repeated brief arousal and recurrent nocturnal desatura-
tion are considered contributing factors. Recently, Cheshire
et al. (26) demonstrated that the frequency of apnoeas plus
hypopnoeas and arousals and the extent of nocturnal
90 H. YAMAMOTO ET AL.hypoxemia are the variables most strongly associated with
cognitive deficits, and that anxiety and depression also
contribute to this impairment. Since nasal CPAP abolished
both the arousal and oxygen desaturation, we could not
dierentiate the cause of improvements on the EDS and the
mood after long-term nasal CPAP treatment. Whatever the
mechanisms of improvements on neuropsychological func-
tions may be, nasal CPAP reduces the rate of trac car
accidents, and improves the EDS, the mood and, finally,
the patient’s quality of life in the long term.
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